OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Statins on nonalcoholic fatty liver disease: A systematic review and meta-analysis of 14 RCTs
Haiyan Zhou, Maeda Toshiyoshi, Wenli Zhao, et al.
Medicine (2023) Vol. 102, Iss. 26, pp. e33981-e33981
Open Access | Times Cited: 15
Haiyan Zhou, Maeda Toshiyoshi, Wenli Zhao, et al.
Medicine (2023) Vol. 102, Iss. 26, pp. e33981-e33981
Open Access | Times Cited: 15
Showing 15 citing articles:
Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers
Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan, et al.
Metabolism (2024) Vol. 160, pp. 156014-156014
Closed Access | Times Cited: 11
Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan, et al.
Metabolism (2024) Vol. 160, pp. 156014-156014
Closed Access | Times Cited: 11
Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review
Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 9
Amedeo Lonardo
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 2
Open Access | Times Cited: 9
From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention
Benedetta Maria Motta, Mario Masarone, Pietro Torre, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5458-5458
Open Access | Times Cited: 19
Benedetta Maria Motta, Mario Masarone, Pietro Torre, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5458-5458
Open Access | Times Cited: 19
Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)
Timo Strandberg, Petri T. Kovanen, Donald M. Lloyd‐Jones, et al.
The Lancet (2024)
Closed Access | Times Cited: 4
Timo Strandberg, Petri T. Kovanen, Donald M. Lloyd‐Jones, et al.
The Lancet (2024)
Closed Access | Times Cited: 4
The significance of metabolism-associated steatotic liver disease and its treatment
Adam Vašura, Evžen Machytka, Marek Bužga, et al.
Vnitřní lékařství (2025) Vol. 71, Iss. 1, pp. 29-36
Closed Access
Adam Vašura, Evžen Machytka, Marek Bužga, et al.
Vnitřní lékařství (2025) Vol. 71, Iss. 1, pp. 29-36
Closed Access
Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment
Marios Zisis, Maria Chondrogianni, Θεόδωρος Ανδρουτσάκος, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 324-324
Open Access
Marios Zisis, Maria Chondrogianni, Θεόδωρος Ανδρουτσάκος, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 324-324
Open Access
Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
В. Т. Ивашкин, О. М. Драпкина, M. V. Maevskaya, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2025) Vol. 35, Iss. 1, pp. 94-152
Open Access
В. Т. Ивашкин, О. М. Драпкина, M. V. Maevskaya, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2025) Vol. 35, Iss. 1, pp. 94-152
Open Access
Role of cholesterol homeostasis in MASH-driven hepatocellular carcinoma: not just a neutral fat
Vicent Ribas
(2024), pp. 203-225
Open Access | Times Cited: 3
Vicent Ribas
(2024), pp. 203-225
Open Access | Times Cited: 3
Revisiting the concepts of de novo lipogenesis to understand the conversion of carbohydrates into fats: stop overvaluing and extrapolating the renowned phrase "fat burns in the flame of carbohydrate"
Heitor O. Santos, Nilson Penha‐Silva
Nutrition (2024) Vol. 130, pp. 112617-112617
Closed Access | Times Cited: 3
Heitor O. Santos, Nilson Penha‐Silva
Nutrition (2024) Vol. 130, pp. 112617-112617
Closed Access | Times Cited: 3
Impact of Rosuvastatin on Metabolic Syndrome Patients with Moderate to Severe Metabolic Associated Fatty Liver Disease without Overt Diabetes: A Randomized Clinical Trial
Xuan Wang, Lu Lyu, Wei Li, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 9, pp. 103126-103126
Open Access | Times Cited: 2
Xuan Wang, Lu Lyu, Wei Li, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 9, pp. 103126-103126
Open Access | Times Cited: 2
Multi-omics profiling reveals altered mitochondrial metabolism in adipose tissue from patients with metabolic dysfunction-associated steatohepatitis
Helena Castañé, Andrea Jiménez-Franco, Anna Hernández‐Aguilera, et al.
EBioMedicine (2024) Vol. 111, pp. 105532-105532
Open Access | Times Cited: 2
Helena Castañé, Andrea Jiménez-Franco, Anna Hernández‐Aguilera, et al.
EBioMedicine (2024) Vol. 111, pp. 105532-105532
Open Access | Times Cited: 2
Choice of antihyprtensive therapy at varios stages of metabolically associated lever disease
L. B. Lasebnik, Л. Н. Чихирева, O. A. Chikhirev, et al.
Experimental and Clinical Gastroenterology (2024), Iss. 11, pp. 52-61
Open Access
L. B. Lasebnik, Л. Н. Чихирева, O. A. Chikhirev, et al.
Experimental and Clinical Gastroenterology (2024), Iss. 11, pp. 52-61
Open Access
Deranged Liver Function Tests Associated With Hyperferritinemia in a Patient With Type 2 Diabetes Mellitus: A Case Study and Literature Review
Erwa Elmakki
Cureus (2024)
Open Access
Erwa Elmakki
Cureus (2024)
Open Access
Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
Zahid Ijaz Tarar, Umer Farooq, Faisal Inayat, et al.
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 4
Closed Access
Zahid Ijaz Tarar, Umer Farooq, Faisal Inayat, et al.
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 4
Closed Access
Actualización del abordaje farmacológico de la enfermedad Esteatósica Asociada a Disfunción Metabólica
Xavier Ramon, Paola Verónica Orellana Bernal
Salud ConCiencia (2023) Vol. 2, Iss. 2, pp. e33-e33
Open Access | Times Cited: 1
Xavier Ramon, Paola Verónica Orellana Bernal
Salud ConCiencia (2023) Vol. 2, Iss. 2, pp. e33-e33
Open Access | Times Cited: 1
